Home|Journals|Articles by Year|Audio Abstracts
 

Original Article

ECB. 2014; 3(4): 362-366


PREPARATION OF NUCLEAR EXTRACTS FROM HeLa CELLS

Muhammad Tahman Shahid, Syeda Khair-ul-Bariyah.




Abstract

Stem cells are the powerful cells derived both from human and animal source. They have the ability to divide innumerably and differentiate into different cell types in the body. HeLa cells are the first immortal human cell lines grown in culture. These cell lines have proved beneficial in the development of polio vaccines and study of various viral cells. The present review aims to cover the studies done through nuclear extracts prepared from HeLa cells. Nuclear extracts from HeLa cells have been used to study the activation of ATM and ATR by double stranded DNA breaks, production of transcriptionally active extracts, analysis of RNA splicing in vitro using T7 RNA polymerasederived splicing substrate RNAs and purification and characterization of proteins. By using these nuclear extracts, the mutational study of proteins still needs to be done to know exact reason of many unknown diseases. Wide variations of pH in extract preparation should be tested to get variations in extract obtained and methods should be modified for desired polypeptide length and to work with extracts at nano scale.

Key words: HeLa cells; nuclear extracts; immortal; cell lines; vaccines; polypeptide; RNA; DNA.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.